mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.6 |
mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.6 |
mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
SB 216763 |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |